Top Page
Mycronic AB
(MYCR)
Mycronic AB (MYCR) vs. iShares MSCI Sweden ETF (EWD)
Mycronic AB Business Overview & Revenue Model
Mycronic AB Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.94B | 7.06B | 5.71B | 5.12B | 4.63B |
| Gross Profit | 4.12B | 3.72B | 2.72B | 2.29B | 2.28B |
| EBITDA | 2.30B | 2.32B | 1.39B | 1.11B | 1.20B |
| Net Income | 1.56B | 1.68B | 998.00M | 741.00M | 828.00M |
Balance Sheet | |||||
| Total Assets | 10.92B | 10.41B | 8.34B | 7.34B | 6.14B |
| Cash, Cash Equivalents and Short-Term Investments | 2.32B | 3.01B | 2.14B | 1.27B | 683.00M |
| Total Debt | 348.00M | 219.00M | 228.00M | 270.00M | 243.00M |
| Total Liabilities | 3.81B | 3.84B | 3.06B | 2.64B | 2.14B |
| Stockholders Equity | 7.11B | 6.53B | 5.25B | 4.66B | 3.96B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 1.64B | 1.41B | 712.00M | 908.00M |
| Operating Cash Flow | 1.41B | 1.87B | 1.61B | 853.00M | 998.00M |
| Investing Cash Flow | -1.13B | -500.00M | -195.00M | 67.00M | -1.22B |
| Financing Cash Flow | -862.00M | -552.00M | -447.00M | -382.00M | -437.00M |
Mycronic AB Technical Analysis
Mycronic AB Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | kr794.41B | 27.46 | 26.43% | 2.03% | -2.38% | -4.00% | |
76 Outperform | kr794.41B | 30.52 | 24.69% | 1.82% | -2.38% | -4.00% | |
73 Outperform | kr215.34B | 23.27 | 20.42% | 1.84% | 3.54% | 20.94% | |
70 Outperform | kr446.81B | 25.67 | 16.39% | 1.94% | -1.77% | 21.13% | |
63 Neutral | kr42.28B | 27.94 | 22.44% | 1.71% | 14.48% | 0.52% | |
61 Neutral | kr79.76B | 24.91 | 9.65% | 1.95% | 2.73% | 7.56% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
Mycronic AB Corporate Events
Mycronic has appointed Annika Haaker as Senior Vice President People & Culture and member of the Executive Management team, with her latest start date set for August 17, 2026. Haaker, who currently serves as Chief People & Culture Officer at Alimak Group and has held senior HR roles at HL Display, Nobia and Nasdaq, is expected to strengthen Mycronic’s global human capital capabilities and support the company’s international growth ambitions.
CEO Anders Lindqvist highlighted Haaker’s broad international HR experience and emphasized that her energy and expertise will add value to the leadership team. The appointment underscores Mycronic’s focus on strategic people management and culture development as it competes in the global market for advanced electronics production equipment.
The most recent analyst rating on (SE:MYCR) stock is a Hold with a SEK207.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic AB reported a record 2025 in terms of both order intake and net sales, with full-year order intake rising 2% to SEK 7.76 billion and net sales up 12% to SEK 7.94 billion, despite currency headwinds. EBIT for the year slipped to SEK 1.94 billion, lowering the EBIT margin to 24% from 29%, as the company stepped up investments in R&D and organizational expansion. In the fourth quarter, order intake fell 19% from last year’s exceptionally strong period, and net sales dipped 2% to SEK 2.02 billion, though revenue grew 10% at constant exchange rates, with weakness in Pattern Generators, PCB Assembly Solutions and High Volume largely offset by strong performance in Global Technologies. The board proposed raising the ordinary dividend to SEK 3.25 per share, reflecting confidence in the company’s financial position, and expects 2026 net sales to reach about SEK 8.25 billion. Strategic moves during the year included agreements to acquire four companies, the post-period acquisition of German test-probe maker ETZ to strengthen the PCB Test line, and the relocation of PCB Assembly Solutions to Kista, Stockholm, improving production capacity and supporting future growth alongside Pattern Generators, while AI-related demand continued to underpin both photomask and die bonding businesses.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK229.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has secured a replacement order from an existing Asian customer for a Prexision 8 Evo mask writer, a system designed to handle complex patterns for advanced display photomasks, with an order value estimated between USD 21 million and USD 24 million and delivery scheduled for the first quarter of 2027. The deal underscores the continued success of Mycronic’s trade-in program, which encourages customers to modernize their installed base, reinforcing the company’s position in the display and semiconductor equipment market and signaling ongoing demand for its high-end pattern generation technology.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK229.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has secured an order worth USD 2–4 million from a new Asian customer for its MMX metrology system, with delivery scheduled for the current quarter, marking an expansion of its footprint in the region’s semiconductor supply chain. The MMX system, built on the SLX mask writer platform and the company’s Prexision-MMS technology, is designed to measure photomask pattern positions for mature semiconductor nodes, positioning Mycronic to replace legacy tools and capture future volume growth while showcasing synergies across its product lines in high-precision metrology.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK229.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has invited analysts, investors and media to a webcast presentation of its fourth-quarter 2025 results on February 5, 2026, with the earnings report to be published the same morning and made available in the company’s online report archive. President and CEO Anders Lindqvist and CFO and Senior Vice President Corporate Development Pierre Brorsson will present the results in English, followed by a Q&A session, underscoring the company’s ongoing efforts to maintain transparent communication with the financial markets and other stakeholders.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK229.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic’s Global Technologies division has acquired German test probe manufacturer ETZ, consolidating control over a key supplier to its PCB Test business line, which provides electrical test equipment for bare board PCBs. ETZ, which generated nearly EUR 4 million in sales in 2025 with about 85 percent coming from Mycronic, will be integrated into the PCB Test business line, a move the company says will secure a strategic core competence in probe development and production while enhancing profitability for its PCB testing operations.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK232.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has secured a USD 5–7 million order from a new Asian customer for its SLX laser mask writer, scheduled for delivery in the first quarter of 2026. The deal underscores growing demand for photomasks in semiconductor manufacturing and highlights the SLX platform’s modern, energy‑efficient design and fast delivery capabilities, reinforcing Mycronic’s position in the pattern generation market as chipmakers upgrade and modernize their production equipment.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK232.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has secured a USD 4–5 million order from an existing Asian customer for its FPS 6100 Evo mask writer, a system aimed at the multi-purpose photomask market serving applications such as electronic packaging, touchscreens and MEMS. The order, scheduled for delivery in the third quarter of 2026, underscores the strong position of Mycronic’s FPS series in the multi-purpose segment and reinforces the company’s role as a key supplier of pattern generation equipment to electronics and semiconductor manufacturers in Asia.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK232.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
Mycronic has received a replacement order from an existing Asian customer for a Prexision 8 Evo mask writer, a system designed to handle complex display photomask patterns, with an order value estimated between USD 14 million and USD 16 million and delivery scheduled for the first quarter of 2027. The deal highlights the strength of Mycronic’s trade-in program in helping customers modernize their installed base, underscoring the company’s entrenched role in the display industry’s high-end photomask segment and supporting ongoing demand for its pattern generator technology in a key Asian market.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK232.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.